期刊文献+

肾癌伴腔静脉癌栓的手术治疗 被引量:1

Surgical Treatment of Renal Cell Carcinoma Complicated by Tumor Thrombi of Inferior Vena Cava
下载PDF
导出
摘要 目的:探讨手术治疗肾癌合并腔静脉癌栓患者的预后。方法:回顾分析2003年12月~2009年12月我院12例经手术及病理证实的肾癌合并腔静脉癌栓患者的资料,其中男性10例,女性2例,中位年龄62(42~76)岁。肾静脉癌栓6例,左侧2例,右侧4例;下腔静脉癌栓Ⅱ级(肝下型)3例,Ⅲ级(肝内型)3例。12例患者术前均经CT或MRI检查明确诊断肾癌合并腔静脉癌栓。结果:12例患者接受肾癌根治术的同时行静脉癌栓切除,术后9例患者得到随访,随访时间6~72个月,无瘤生存1~3年4例,生存5年以上的4例,1例术后6个月死于肿瘤复发。结论:CT和MRI对肾癌伴下腔静脉癌栓诊断率较高,可准确判断癌栓位置,对无淋巴结和远处转移者,在行肾癌根治术的同时行下腔静脉癌栓取出术是治疗肾癌合并静脉瘤栓积极有效的治疗方法。 Objective: To summarize our experience on surgical treatment of renal cell carcinoma with tumor thrombi of inferior vena cava. Methods: This retrospective study involved 12 patients with renal cell carcinoma complicated with tumor thrombi of inferior vena cava. Radical nephrectomy plus vena cava thrombus removal were conducted in our hospital during the period from December 2003 to December 2009. Results: Final diagnosis of renal carcinoma complicated by tumor thrombi of vena cava was made in all 12 patients following preoperative CT scan and MRI examination. Tumor thrombi of renal vein or inferior vena cava were found in all the patients, with 2 of the 12 cases having the tumor embolus of left renal vein, 4 having tumor embolus of right renal vein, and 6 suffering the tumor embolus of vena cava (3 with sub-hepatic vena cava and the other 3 with intra-hepatic vena cava). All patients underwent radical nephrectomy and thrombectomy concurrently. Nine of the 12 patients were followed up for a period ranging from 6 to 72 months after surgery. Four of the 12 patients survived disease-free for 1 to 3 years, 4 survived disease-free for more than 5 years, and 1 died with tumor recurrence 6 months after surgery. Conclusion: Radical nephrectomy plus removal of vena cava thrombus can achieve a long-term survival for patients with renal cell carcinoma and vena cava thrombi and without regional and distant metastases.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2010年第14期817-819,共3页 Chinese Journal of Clinical Oncology
关键词 肾肿瘤 肾静脉 下腔静脉 栓子 Renal carcinoma Renal vein Inferior vena cava Carcinoma Embolus
  • 相关文献

参考文献5

二级参考文献45

  • 1李晓飞,周芳坚,丘少鹏,刘卓炜,吴荣佩,黄凯,梅骅.肾癌腔静脉癌栓的诊断与治疗[J].癌症,2004,23(9):1074-1076. 被引量:19
  • 2蔡松良,罗金旦,万群,张志根,金百冶,陈戈明.肾癌伴下腔静脉癌栓的诊断与治疗[J].中华泌尿外科杂志,2005,26(8):516-519. 被引量:28
  • 3张雨涛,陈铌,曾浩,周桥.肿瘤抑制基因VHL、低氧诱导因子与肾细胞癌[J].中华病理学杂志,2006,35(9):562-564. 被引量:6
  • 4Berg AA. Malignant hypernephroma of kidney, its clinical course and diagnosis, with a description of the author 's method of radical operative cure. Surg Gynecol Obstet, 1913, 17:463 471.
  • 5Vaidya A, Ciancio G, Soloway M. Surgical techniques for treating a renal neoplasm invading the inferior vena cava. J Urol, 2003, 169:435-444.
  • 6Coulange C, Hardwigsen J, Le Treut P. Renal cell eareinoma: management of venous thrombus. Ann Urol (Paris), 2006, 40 (Suppl 3) :77-81.
  • 7Baumgartner F, Scott R, Zane R, et al. Modified venovenous bypass technique for resection of renal and adrenal carcinoma with involvement of the inferior vena cava. Eur J Surg, 1996, 162: 59-62.
  • 8Browning AJ, Eardley I, Joyce AD, et al. Percutaneous venovenous bypass in surgery for renal cell carcinoma with associated vena caval tumour thrombus. BJU Int, 1999, 83: 850- 852.
  • 9Gonzalez Martin M, Chantada Abal V, Alvarez Castelo LM, et al. Renal carcinoma with tumor thrombus in the vena cava and auricle. Experience and review. Arch Esp Urol, 1998, 51: 44-53.
  • 10Zini L, Koussa M, Haulon S, et al. Results of endoluminal occlusion of the inferior vena during radical nephrectomy and thrombectomy. Eur Urol, 2008, 54: 778-783.

共引文献28

同被引文献17

  • 1Harshman LC,Yu RJ,Allen GI,et al. Surgical outcomes and compli - cations associated with presurglcal tyrosine kinase inhibition for advanced renal cell carcinoma (RCC) [J]. Urol. Oncol, 2013,31: 379-385.18.
  • 2Guo J, Huang YR,Zhang X,et al.Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy:an open-label phase lb study[J]. BMC Cancer,2013,13:136.
  • 3National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: kidney cancer.2013.V1.May 12th,2012.
  • 4Procopio G, Bellmunt J, Dutcher J, et al. Sorafenib tolerability in elderly patients with advanced renal cell carcinoma:results from a large pooled analysis[J].Br J Cancer,2013,108:311-318.
  • 5Bergmann L,Goebell PJ,Kube U,et al.Everolimus in metastatic renal cell carcinoma after failure of initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: results of an interim analysis of a non-interventional study[J]. Oncology,2013,36:95-100.
  • 6王权,周文生.小肾癌的治疗策略[J].中华全科医学,2010,8(12):1590-1592. 被引量:5
  • 7张志强,于德新,方卫华,江山,施浩强,廖贵益,赵磊.年龄和环境对肾细胞癌临床病理特征的影响[J].实用癌症杂志,2010,25(6):642-645. 被引量:1
  • 8韩精超,纪志刚,李汉忠.肾部分切除术治疗肾肿瘤的安全性及疗效分析[J].中华泌尿外科杂志,2011,32(5):303-306. 被引量:37
  • 9程洋生,周盛川,符建.腹膜后腹腔镜下肾切除术临床应用体会[J].中国伤残医学,2011,19(4):15-16. 被引量:1
  • 10王志向,王林辉.肾癌生长速度的研究进展[J].现代泌尿外科杂志,2012,17(4):425-427. 被引量:3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部